HIMS vs ALKS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
HIMS · Hims & Hers Health$26.00 ▲ 8.06%
ALKS · Alkermes$45.90 ▲ 3.05%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- HIMS -36.7%
- ALKS +40.6%
Head to head
| Metric | HIMS | ALKS |
|---|---|---|
| Price | $26.00 | $45.90 |
| Change today | ▲ 8.06% | ▲ 3.05% |
| Market cap | $6.07B | $7.71B |
| Return, 3 months | -18.2% | -7.1% |
| Return, year to date | -19.9% | +64.0% |
| Return, 1 year | -36.6% | +39.6% |
| P/E (TTM) | – | – |
| P/B | 18.7 | 4.1 |
| P/E percentile vs own 5y | 24th | 97th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +38.2% | +27.0% |
| Net profit growth (YoY) | -303.0% | -99.4% |
| Gross margin | 68.4% | 84.6% |
| Operating margin | -6.0% | 8.6% |
| Net margin | -5.5% | 4.0% |
| Return on equity | -32.0% | 3.9% |
| Analyst target vs. price | +33.2% | +30.3% |
| Analyst buy share | 27% | 73% |
| RSI (14) | 44 | 60 |
| 30-day volatility | 74.5% | 31.6% |
| Max drawdown, 1 year | -69.9% | -29.2% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ALKS is the largest of the group by market value.
- ALKS has returned the most over the past year.
- HIMS is growing revenue fastest.
- ALKS keeps the most profit per dollar of sales.
- ALKS has been the calmest stock over the last 30 days.